Opportunity Information: Apply for RFA DA 11 004
Apply for RFA DA 11 004
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Aug 26, 2010 and posted on Aug 26, 2010.
- Applicants must submit their applications by Jan 13, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41) opportunity, issued by the National Institute on Drug Abuse (NIDA) under the National Institutes of Health, is a discretionary grant program focused on accelerating the early-stage development of new and more effective pharmacological treatments for tobacco dependence. In practical terms, the announcement is designed to help move promising treatment agents and improved drug formulations from concept toward validated feasibility, with the broader public health aim of improving smoking cessation outcomes and reducing the harms associated with nicotine addiction.
This funding opportunity uses the Small Business Technology Transfer (STTR) Phase I mechanism, specifically the R41 award. Phase I STTR awards typically support proof-of-concept and feasibility research, meaning applicants are expected to demonstrate that a proposed therapeutic approach or formulation has enough preliminary support to justify further development. The STTR structure also emphasizes formal collaboration between a small business concern and a nonprofit research institution, reflecting NIHs intent to blend commercial development capability with academic or research-based scientific expertise. Eligible applicants are small businesses, and the announcement does not require cost sharing or matching funds.
For this particular solicitation (Funding Opportunity Number RFA-DA-11-004), NIDA anticipated supporting roughly 4 to 7 projects, with an estimated total funding pool of $1,500,000 for fiscal year 2011, subject to the availability of appropriations in future years. Individual Phase I projects could request up to $300,000 in total costs for a project period of up to one year, which sets clear expectations for both the scale and timeline of the proposed work. The program falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs) and is categorized within education and health funding activities, reflecting its role in advancing applied biomedical research that can translate into real-world clinical tools.
Key administrative details include a posted and creation date of August 26, 2010, with an original and current closing date of January 13, 2011, and an archive date of February 13, 2011, indicating the opportunity is no longer open but remains accessible for reference. The full announcement was hosted through the NIH grants guide, and applicants or readers who encountered access or linking problems were directed to contact the NIH Office of Extramural Research (OER) webmaster via the provided email addresses.
Frequently Asked Questions (FAQs)
What is the focus of the "Pharmacological Development of Treatment Agents and Formulations for Tobacco Dependence (STTR R41)" opportunity?
This opportunity focuses on accelerating early-stage development of new and more effective pharmacological treatments for tobacco dependence. It is intended to help move promising treatment agents and improved drug formulations from initial concept toward validated feasibility, with the broader public health goal of improving smoking cessation outcomes and reducing harms associated with nicotine addiction.
Which agency issued this funding opportunity?
The opportunity was issued by the National Institute on Drug Abuse (NIDA) under the National Institutes of Health (NIH).
What type of grant mechanism does this announcement use?
This announcement uses the Small Business Technology Transfer (STTR) Phase I mechanism, specifically the R41 award.
What is the purpose of an STTR Phase I (R41) award in this program?
Phase I STTR awards typically support proof-of-concept and feasibility research. Under this solicitation, applicants were expected to demonstrate that a proposed therapeutic approach or formulation has enough preliminary support to justify further development.
Who is eligible to apply?
Eligible applicants are small businesses. The STTR structure also emphasizes formal collaboration between a small business concern and a nonprofit research institution.
Does this STTR opportunity require collaboration with a research institution?
Yes. The STTR structure emphasized formal collaboration between a small business concern and a nonprofit research institution, reflecting an intent to combine commercial development capacity with academic or research-based scientific expertise.
Is cost sharing or matching funds required?
No. The announcement stated that cost sharing or matching funds are not required.
How many awards did NIDA expect to make under this solicitation?
NIDA anticipated supporting roughly 4 to 7 projects, subject to the availability of appropriations in future years.
What was the estimated total funding amount available?
The estimated total funding pool was $1,500,000 for fiscal year 2011, subject to the availability of appropriations in future years.
What was the maximum budget and project period for an individual Phase I project?
Individual Phase I projects could request up to $300,000 in total costs for a project period of up to one year.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is RFA-DA-11-004.
What CFDA program does this opportunity fall under?
The opportunity falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
How is this program categorized in terms of funding activities?
It is categorized within education and health funding activities, reflecting its role in advancing applied biomedical research that can translate into real-world clinical tools.
When was the opportunity posted, and what were the closing dates?
The posted and creation date was August 26, 2010. The original and current closing date was January 13, 2011.
Is this funding opportunity still open?
No. The archive date was February 13, 2011, indicating the opportunity is no longer open and is available for reference only.
Where was the full announcement hosted?
The full announcement was hosted through the NIH grants guide.
Who should be contacted if there are access or linking problems with the announcement?
Applicants or readers who encountered access or linking problems were directed to contact the NIH Office of Extramural Research (OER) webmaster via the provided email addresses.
Browse more opportunities from the same category: Education Health
Next opportunity: Educational Internships Youth Initiative, Alaska
Previous opportunity: Buffelgrass Mitigation on Public Lands and Transportation Corridors Adjoining Saguaro National Park
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 11 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 11 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing and Improving Institutional Animal Resources (G20) Apply for RFA RR 10 011 Funding Number: RFA RR 10 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44) Apply for RFA CA 10 013 Funding Number: RFA CA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Assay Development for High Throughput Screening for Nicotinic Receptor Subunits (R21) Apply for RFA DA 11 007 Funding Number: RFA DA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Apply for PAR 10 283 Funding Number: PAR 10 283 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR U43/U44) Apply for PAR 10 286 Funding Number: PAR 10 286 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 11 002 Funding Number: RFA DA 11 002 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre Application for the 2011 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 287 Funding Number: PAR 10 287 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Resource Related Research Projects for Development of Animal Models and Related Materials (R24) Apply for PAR 10 289 Funding Number: PAR 10 289 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R01) Apply for PA 10 290 Funding Number: PA 10 290 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Malignancies in the Context of HIV/AIDS (R21) Apply for PA 10 291 Funding Number: PA 10 291 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Tumor Microenvironment Network (TMEN) (U54) Apply for RFA CA 10 021 Funding Number: RFA CA 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $700,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 11 001 Funding Number: PAR 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 11 005 Funding Number: PAR 11 005 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Comprehensive Partnerships to Reduce Cancer Health Disparities (U54) Apply for RFA CA 11 001 Funding Number: RFA CA 11 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Translational Scholar Career Awards in Pharmacogenomics and Personalized Medicine (K23) Apply for PA 11 009 Funding Number: PA 11 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R03) Apply for PA 11 008 Funding Number: PA 11 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R01) Apply for PA 11 006 Funding Number: PA 11 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Substance Use and Abuse, Risky Decision Making and HIV/AIDS (R21) Apply for PA 11 007 Funding Number: PA 11 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| HIV Infection of the Central Nervous System (R01) Apply for PA 11 014 Funding Number: PA 11 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| National Gene Vector Biorepository and Coordinating Center (P40) Apply for RFA RR 10 010 Funding Number: RFA RR 10 010 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 11 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.